155 related articles for article (PubMed ID: 3898458)
1. Comparative evaluation of two outpatient antiemetic regimens for cancer chemotherapy.
Pruitt BT; Justice RL; Periman P
Tex Med; 1985 Jul; 81(7):44-5. PubMed ID: 3898458
[No Abstract] [Full Text] [Related]
2. Tropisetron (Navoban) alone and in combination with dexamethasone in the prevention of chemotherapy-induced emesis: the Nordic experience.
Sorbe BG
Semin Oncol; 1994 Oct; 21(5 Suppl 9):20-6. PubMed ID: 9113123
[TBL] [Abstract][Full Text] [Related]
3. Suitability of long-acting metoclopramide for prophylaxis of chemotherapy-induced delayed nausea and vomiting.
Wilder-Smith C; Schimke J; Vergin H; Senn HJ
Arzneimittelforschung; 1989 Nov; 39(11):1464-7. PubMed ID: 2619781
[TBL] [Abstract][Full Text] [Related]
4. Prevention of chemotherapy-induced nausea and vomiting by tropisetron (Navoban) alone or in combination with other antiemetic agents.
Bruntsch U; Drechsler S; Eggert J; Gosse H; Ukena D; Imhoff W; Faerber L
Semin Oncol; 1994 Oct; 21(5 Suppl 9):7-11. PubMed ID: 9113120
[TBL] [Abstract][Full Text] [Related]
5. [Nausea and vomiting during treatment with cytostatics].
Kaasa S; Mella O; Kvikstad A
Tidsskr Nor Laegeforen; 1991 Mar; 111(8):941-4. PubMed ID: 2042209
[TBL] [Abstract][Full Text] [Related]
6. [The antiemetic effect and clinical evaluation of metoclopramide alone and combined with betamethasone in children with malignant tumor].
Hatae Y; Takeda T; Nakadate H; Hatayama Y; Kishino T; Ogawa Y
Gan To Kagaku Ryoho; 1989 Nov; 16(11):3639-42. PubMed ID: 2817913
[No Abstract] [Full Text] [Related]
7. A report comparing the use of tropisetron (Navoban), a 5-HT3 antagonist, with a standard antiemetic regimen of dexamethasone and metoclopramide in cisplatin-treated patients under conditions of severe emesis.
Madej G; Krzakowski M; Pawinski A; Lasota W; Rogowski W; Skoneczna I
Semin Oncol; 1994 Oct; 21(5 Suppl 9):3-6. PubMed ID: 9113119
[TBL] [Abstract][Full Text] [Related]
8. Nabilone and high-dose metoclopramide: anti-emetics for cancer chemotherapy.
Drug Ther Bull; 1984 Feb; 22(3):9-11. PubMed ID: 6321126
[No Abstract] [Full Text] [Related]
9. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
10. Prevention of cisplatin-induced delayed emesis: still unsatisfactory. Italian Group for Antiemetic Research.
Support Care Cancer; 2000 May; 8(3):229-32. PubMed ID: 10789965
[TBL] [Abstract][Full Text] [Related]
11. Ondansetron in the treatment of nausea and vomiting. Introduction.
Marschner N
Anticancer Drugs; 1993 Dec; 4 Suppl 2():3-7. PubMed ID: 8136513
[No Abstract] [Full Text] [Related]
12. Antiemetic efficacy of dexamethasone therapy in patients receiving cancer chemotherapy.
Cassileth PA; Lusk EJ; Torri S; DiNubile N; Gerson SL
Arch Intern Med; 1983 Jul; 143(7):1347-9. PubMed ID: 6347109
[TBL] [Abstract][Full Text] [Related]
13. Low-dose metoclopramide versus methylprednisolone in controlling chemotherapy induced nausea and vomiting.
Chiara S; Scarsi P; Campora E; Bruzzi P; Tatarek R; Rosso R
Chemioterapia; 1984 Oct; 3(5):333-6. PubMed ID: 6398127
[TBL] [Abstract][Full Text] [Related]
14. Improved control of chemotherapy-induced emesis by the addition of dexamethasone to metoclopramide in patients resistant to metoclopramide.
Bruera ED; Roca E; Cedaro L; Chacón R; Estévez R
Cancer Treat Rep; 1983 Apr; 67(4):381-3. PubMed ID: 6342770
[TBL] [Abstract][Full Text] [Related]
15. Navoban (tropisetron) alone and in combination with dexamethasone in the prevention of chemotherapy-induced nausea and vomiting: the Nordic experience. The Nordic Antiemetic Trial Group.
Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Andersson H; Hansen O; Sørensen BT; Räisänen I
Anticancer Drugs; 1995 Feb; 6 Suppl 1():31-6. PubMed ID: 7749168
[TBL] [Abstract][Full Text] [Related]
16. Use of dexamethasone with 5-HT3-receptor antagonists for chemotherapy-induced nausea and vomiting.
Perez EA
Cancer J Sci Am; 1998; 4(2):72-7. PubMed ID: 9532406
[TBL] [Abstract][Full Text] [Related]
17. [An outline of 5-HT3 receptor antagonists (2)--In clinical applications].
Tsukagoshi S; Ohta J; Taguchi T
Gan To Kagaku Ryoho; 1993 Dec; 20(15):2276-81. PubMed ID: 8259839
[TBL] [Abstract][Full Text] [Related]
18. Clinical practice guidelines on antiemetics in oncology.
Aranda Aguilar E; Constenla Figueiras M; Cortes-Funes H; Diaz-Rubio García E; Gascon Vilaplana P; Guillém V; Martin-Algarra S
Expert Rev Anticancer Ther; 2005 Dec; 5(6):963-72. PubMed ID: 16336087
[TBL] [Abstract][Full Text] [Related]
19. Antiemetic efficacy of high-dose dexamethasone: randomized, double-blind, crossover study with a combination of dexamethasone, metoclopramide and diphenhydramine.
al-Idrissi HY; Ibrahim EM; Abdullah KA; Ababtain WA; Boukhary HA; Macaulay HM
Br J Cancer; 1988 Mar; 57(3):308-12. PubMed ID: 3281702
[TBL] [Abstract][Full Text] [Related]
20. [Clinical evaluation of antiemetics for vomiting due to cancer chemotherapy in children].
Ise T; Ohira M; Omiya A; Hirose M; Shibata T
Gan To Kagaku Ryoho; 1982 Jul; 9(6):1108-18. PubMed ID: 6764113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
